Skip to main content

Table 1 Study population and indications for EUS

From: The role of endoscopic ultrasound in children with Pancreatobiliary and gastrointestinal disorders: a single center series and review of the literature

Children/Procedures [n] 40/47
Females/Males [n] 18/22
Age [y, range] 3–18
[y, mean ± SD] 15.1 ± 4.7
Indications for EUS [n (%)]
 Upper-GI EUS 32 (68.1)
  • Suspected CBDs 8
  • Acute biliary pancreatitis 7
  • Recurrent/chronic pancreatitis 4
  • Suspected CBDs in patients with UC 3
  • Cystic pancreatic mass 3
  • Recurrent hypoglycemia 2
  • Duodenal polyp 2
  • Pseudocyst drainage 1
  • Gastric submucosal lesion 1
  • Perigastric abscess 1
Lower-GI EUS 15 (31.9)
  • Suspected anal Crohn’s Disease 12
  • Fecal incontinence 2
  • Encopresis 1
EUS-FNA [n (%)] 3 (6.4)
EUS procedures with sedation [n (%)]
Upper GI
• Deep sedation 22 (46.8)
• General anesthesia 10 (21.3)
Lower GI
• No sedation 14 (29.8)
• Deep sedation 1 (2.1)
Anesthesia-related adverse events [n (%)] 0
Clinical Impact of EUS [n (%)]
• Score 0 6 (12.8)
• Score 1 24 (51)
• Score 2 17 (36.2)
Significant impact (score 1 + 2) 41 (87.2)
  1. EUS indicates endoscopic ultrasound; CBDs indicates common bile ducts stones; UC indicates ulcerative colitis; FNA indicates fine needle aspiration; GI indicates gastrointestinal